REYKJAVIK, Iceland, Feb. 7 deCODE genetics(Nasdaq: DCGN) today announced that it will host a live webcast of deCODEChief Scientific Officer Jeffrey Gulcher's presentation at BiotechnologyIndustry Organization (BIO) CEO and Investor Conference.
The presentation will be delivered at 2:45 PM ET / 19:45GMT on Monday,February 11 at the Waldorf-Astoria hotel in New York. The webcast can beaccessed through the Investors page on deCODE's website,http://www.decode.com, and those interested in listening should log on a fewminutes in advance in order to download any software or complete any sign-inthat may be required. The webcast will be archived for at least one week.
deCODE genetics (Nasdaq: DCGN) is a global leader in applying humangenetics to develop drugs and diagnostics for common diseases. Our populationapproach has enabled us to discover and target key biological pathwaysinvolved in conditions ranging from heart attack to cancer. We are turningthese discoveries into new medicine to better treat and prevent many of thebiggest challenges to public health. deCODE is delivering on the promise ofthe new genetics(SM). Visit us on the web at http://www.decode.com.Contact: deCODE genetics Kristin H. Barkardottir +354-570-2847 firstname.lastname@example.org
SOURCE deCODE genetics